A 3917 New Jersey General Assembly · 2018-2019 Regular Session

Requires pharmaceutical manufacturers and wholesale distributors to annually report certain manufacturing and dispensing information concerning prescription opioid drugs, medication-assisted treatment drugs, and opioid antidote drugs.

Bill status in committee 1 of 4 stages cleared
Introduction
May 2018
Committee Review
Floor Vote
Governor
Introduced May 7, 2018 Last action May 7, 2018
Floor votes

How they voted

No floor votes recorded yet.
Full legislative history

Actions timeline

Total actions
1
Key actions
0
Committee
0
May 7, 2018
General Assembly · Introduced
Introduced in the Assembly, Referred to Assembly Health and Senior Services Committee
0 primary · 0 co-sponsors

Sponsors

No sponsor information available.